Elekta announces strategic partnership with the Centre hospitalier de l’Université de Montréal
MONTREAL, Canada, May 7 – Elekta has signed an agreement to provide the Centre hospitalier de l'Université de Montréal* (CHUM) with advanced linear accelerators and software. The order, resulting from a competitive tender process, is valued at more than USD 20 million and was booked during Elekta’s fourth quarter of its fiscal year 2013/14.
The CHUM was formed through the merger of three teaching hospitals, including the 372-year old Hôtel-Dieu Hospital. It is one of the largest hospitals in Canada and a leading academic center in the province of Quebec. To increase the efficiency of its new integrated cancer center, the CHUM has chosen Elekta’s MOSAIQ® oncology information system to manage the complete spectrum of oncology treatments in a single patient record accessible by its 17 multi-disciplinary teams across multiple locations.
The partnership agreement also includes Elekta Infinity™ linear accelerators with Agility™ multileaf collimators. At the core of a new radiotherapy treatment platform, this sophisticated technology will offer CHUM’s clinicians superior dose conformance and treatment speed as well as high-resolution beam shaping. For patients, it means safer, faster treatment with less risk of damage to healthy tissue.
Dr. David Roberge, Head of Radiation Oncology at CHUM, says: “We chose Elekta, not simply for the advanced capabilities of its linear accelerators, but because of our shared vision for improving cancer management. Together, we will better integrate our cancer care activities — whether it be clinical research, screening, surgery, systemic therapy, radiation, survivorship or palliative care. MOSAIQ will ensure that patients have the most efficient management options available.”
Jay Hoey, Executive Vice President of Region North America, says: “This is another example of how Elekta is aligning with comprehensive cancer programs to lead the future of cancer care together. We hope to establish MOSAIQ as the primary electronic medical record solution for cancer care across the province, thereby enhancing the experience for cancer patients and providers.”
Michael Power, Vice President and Managing Partner for Elekta Canada, says: “Elekta is already well positioned in Quebec, and with this strategically important partnership, our commitment to the region will be even stronger.”
*University of Montreal Health Centre
# # #
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: firstname.lastname@example.org
Time zone: CET: Central European Time
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: email@example.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on May 7, 2014.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.